Answers are grounded in this paper and cite their sources.
Advances in analytical methods, imaging techniques and an increased understanding of the influence of pharmacogenetic factors have added to our knowledge of the pharmacology of many chemotherapeutic agents. Extending the use of these approaches to pharmacodynamic end-points, together with the application of population-based modelling techniques, offers the potential to develop truly individualized therapy in the future.
No takes yet. Share an insight, caveat, or question.
Alan V. Boddy (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: